CareRx Corp's stock has seen a modest decline this week, reflecting broader market sentiments.
This week, CareRx Corp (CRRX.TO) experienced a slight dip in its stock price, closing at C$3.38, down 1.43% on the day and 2.54% over the week. Despite this downturn, the stock has performed well over the past month, gaining 9.52%. In this update, weโll explore the factors affecting CareRx's stock performance and the technical indicators investors should consider.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$222.06M
P/E
8.1x
52W high
$3.95
52W low
$2.64
1W change
-2.54%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 49.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+49.1% Upside
Current Price
C$3.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
24.3%
Annualized
90-Day Vol
26.4%
Annualized
Trend (90d)
-42.8%
Annualized drift
90d Mean
C$2.96
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.28 | C$3.01 โ C$3.57 |
| 60 trading days | C$3.12 | C$2.77 โ C$3.51 |
| 90 trading days | C$2.96 | C$2.56 โ C$3.42 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: While CareRx's stock has faced some short-term volatility, its recent financial results and dividend declarations suggest a stable outlook for long-term investors. Keeping an eye on the company's performance alongside its technical indicators could provide insights for future investment decisions.
CareRx Corp's stock closed at C$3.38, down 1.43% today.
With a market cap of approximately C$222 million and a P/E ratio of 8.14, CareRx presents a potentially attractive valuation compared to industry peers, especially with a profit margin of 7.2% and a return on equity of 27.5%.
Bull case
CareRx's recent financial results show increased Adjusted EBITDA and reduced net debt, indicating a company on solid footing. The average analyst target of C$5.14 suggests potential for growth, with an implied upside of over 52%. Additionally, the company's consistent dividend declarations may attract income-focused investors.
Bear case
Despite positive long-term fundamentals, CareRx's stock has struggled this year, down 11.08%. The current price is below both the 50-day and 200-day moving averages, indicating potential bearish sentiment. Furthermore, trading volume is significantly lower than the 20-day average, suggesting reduced investor interest.
Recent Price Action
CareRx Corp's stock closed at C$3.38, down 1.43% on the day and 2.54% for the week. This decline comes despite a positive performance over the past month, where the stock gained 9.52%. Investors may be weighing recent company announcements against broader market conditions.
Company News & Catalysts
There were no major news items reported this week that directly impacted CareRx Corp's stock price. However, the company previously announced its Q1 2026 financial results, showcasing an increase in Adjusted EBITDA and a decrease in net debt. CareRx also declared a dividend of CAD$0.02 per share, demonstrating its commitment to returning value to shareholders.
Technical Picture
From a technical standpoint, CareRx is currently trading below both its 50-day moving average (C$3.40) and its 200-day moving average (C$3.62), indicating a bearish trend. The stock has a beta of 0.60, suggesting lower volatility compared to the broader market. The 52-week range for CareRx is C$2.64 to C$3.95, positioning the current price at approximately 56% of its range. Trading volume has been low, with the latest volume at 4,514 shares compared to a 20-day average of 14,574 shares.
Advertisement
